Cell‐mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression

96Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

The chronic fatigue syndrome (CFS) is characterized by severe persistent fatigue and neuropsychiatric symptoms. It has been proposed that the abnormalities in cell‐mediated immunity which have been documented in patients with CFS may be attributable to a clinical depression, prevalent in patients with this disorder. Cell‐mediated immune status was evaluated in patients with carefully defined CFS and compared with that of matched subjects with major depression (non‐melancholic, non‐psychotic) as well as healthy control subjects. Patients with CFS demonstrated impaired lymphocyte responses to phytohaemagglutinin (PHA) stimulation, and reduced or absent delayed‐type hypersensitivity (DTH) skin responses when compared either with subjects with major depression or with healthy control subjects (P < 0·05 for each analysis). Although depression is common in patients with CFS, the disturbances of cell‐mediated immunity in this disorder differ in prevalence and magnitude from those associated with major depression. These observations strengthen the likelihood of a direct relationship between abnormal cell‐mediated immunity and the etiology of CFS. Copyright © 1992, Wiley Blackwell. All rights reserved

Author supplied keywords

Cite

CITATION STYLE

APA

LLOYD, A., HICKIE, I., HICKIE, C., DWYER, J., & WAKEFIELD, D. (1992). Cell‐mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clinical & Experimental Immunology, 87(1), 76–79. https://doi.org/10.1111/j.1365-2249.1992.tb06416.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free